Pheno Therapeutics Limited

ActiveSC612347 Private limited company

What Pheno Therapeutics say about themselves

“Delivering a new class of neuroprotective therapeutics by harnessing the potential of GPR17 biology”

— from phenotherapeutics.com
Incorporated
31 October 2018 (8 years)
Previously known as
Jagger Therapeutics Limited (until 12 February 2019)
Industry
Other professional, scientific and technical activities n.e.c. (74909)
Accounts type
Small
Region
Scotland
Address
Citypoint
3rd Floor
65 Haymarket Terrace
Edinburgh
EH12 5HD

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt filed
9 November 2026
Last conf. stmt
30 October 2026

Officers 6 active

Officer details are public data from the Companies House register.

Director · Appointed 2 April 2024
British
Born February 1982 (44)
Director · Appointed 5 December 2022
British
Born January 1982 (44)
Director · Appointed 5 May 2022
British
Born May 1971 (55)
Director · Appointed 1 March 2022
American
Born April 1968 (58)
Harris, Timothy John Roy, Dr
Director · Appointed 3 December 2019
American
Born May 1950 (76)
Director · Appointed 28 March 2019
British
Born May 1966 (60)
Officer history (9 former)
24 October 2025
Resigned Thorntons Law LLP as Corporate Secretary
2 April 2024
Resigned Parekh, Rajesh Bhikhu, Dr as Director
2 April 2024
Appointed Schmidt, Dominic, Dr as Director
6 December 2022
Appointed Parekh, Rajesh Bhikhu, Dr as Director
5 December 2022
Appointed Mir, Sohaib, Dr as Director
5 December 2022
Resigned Millan, Enrique, Dr as Director
18 November 2022
Resigned Shahid, Mohammed, Dr as Director
5 May 2022
Resigned Murray, John Fraser, Dr as Director
5 May 2022
Appointed Murray, John Fraser, Dr as Director
5 May 2022
Appointed Murray, John Fraser, Dr as Director
3 May 2022
Resigned Parekh, Rajesh Bhikhu, Dr as Director
2 March 2022
Resigned Moore, Jonathan David, Dr as Director
1 March 2022
Appointed Shahid, Mohammed, Dr as Director
1 March 2022
Appointed Rhodes, Jane Kathleen Relton as Director
3 December 2019
Appointed Harris, Timothy John Roy, Dr as Director
18 November 2019
Appointed Millan, Enrique, Dr as Director
28 March 2019
Appointed Parekh, Rajesh Bhikhu, Dr as Director
28 March 2019
Appointed Chandran, Siddharthan, Professor as Director
22 March 2019
15 March 2019
Appointed Moore, Jonathan David, Dr as Director
28 January 2019
Appointed Carragher, Neil Oliver, Professor as Director
28 January 2019
Resigned Lang, Alistair James as Director
31 October 2018
Appointed Lang, Alistair James as Director
31 October 2018
Appointed Thorntons Law LLP as Corporate Secretary

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 28 October 2022
Owns 50–75% of shares (as a firm)
Limited Liability Partnership
Reg. no. Oc347034
Former controllers (3)
28 October 2022
Ceased Advent Life Sciences LLP — Owns 50–75% of shares (as a firm)
25 March 2019
Ceased Neil Oliver Carragher — Owns 75–100% of shares
1 March 2019
Ceased Murray Donald Trustees Limited — Owns 75–100% of shares

Group structure 17 companies

Ownership group derived from the Companies House PSC register

Advent Life Sciences GP LLP Right to 75–100% of surplus assets
Advent LS Services Limited Owns 75–100% of shares
Als Growth GP LLP Right to 75–100% of surplus assets
Als Iii Carry and Co-Invest GP LLP Holds 25–50% of voting rights
Als Carry LP Has significant influence or control
Als Iii Carry and Co-Invest LP Part right to 50–75% of surplus assets (as a firm)
Als Iii GP LLP Holds 75–100% of voting rights
Als Iii Member Co Limited Owns 75–100% of shares
Als IV Carry and Co-Invest LP Part right to 75–100% of surplus assets
Als IV Carry and Co-Invest GP LLP Holds 25–50% of voting rights
Alsgf Carry and Co-Invest GP LLP Holds 25–50% of voting rights
Alsgf Carry and Co-Invest LP Has significant influence or control
Cenentry Biosciences Limited Owns 25–50% of shares
Fiera Oncology Limited Owns 25–50% of shares
Pheno Therapeutics Limited This company Owns 50–75% of shares (as a firm)
Ventus Medical Limited Owns 75–100% of shares

Financials

Balance sheet as at 31 December 2025 · small accounts

Net Assets
(£9,633,470)
Cash
£1,742,507
Profit
(£2,907,765)
Debt Ratio
565%
Current Ratio
0.2x
Balance sheet detail
2025
Fixed Assets£0
Current Assets£2,070,389
Debtors£327,882
Cash£1,742,507
Creditors (< 1 year)£9,364,870
Net Current Assets(£7,294,481)
Net Assets(£9,633,470)
Shareholder Funds(£9,633,470)

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
9 November 2026Confirmation statement with updates30 October 2026

Some other companies at this address

Other companies in this industry

By trade and location

New companies in Edinburgh →

Explore the largest companies

Largest companies in Edinburgh, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?